Literature DB >> 2122130

Cognitive development in offspring of untreated and preconceptionally treated maternal phenylketonuria.

F Güttler1, H Lou, J Andresen, K Kok, I Mikkelsen, K B Nielsen, J B Nielsen.   

Abstract

A survey is given of literature reports on the effect of performance in offspring from 26 maternal PKU pregnancies treated prior to conception. The survey includes two women who were referred to us for genetic counselling because they had both given birth to microcephalic, mentally retarded children. The women were discovered to suffer from unrecognized maternal PKU with fasting phenylalanine concentration of 1.1-1.5 mmol/L. A strict diet was introduced prior to planned pregnancy and after some months on diet (phenylalanine concentrations less than 0.6 mmol/L) they became pregnant again. Serum phenylalanine levels were monitored weekly throughout pregnancy, and adjustments in the diet were made to keep serum phenylalanine concentration within the range of 0.18-0.42 mmol/L. The outcome of the pregnancies were healthy children who have developed normally. Their IQs are 105 and 119 at ten and four years of age, respectively and their head circumferences are normal. Our data show that the effect of preconceptional dietary treatment was children with a normal performance, contrary to their older siblings born following untreated pregnancies. These results are in agreement with the survey of ten years' promising experiences with preconceptional treatment in maternal PKU. The data may help to motivate young PKU women to accept planned pregnancies and to encourage them to return to the strict diet, which has prevented them from being retarded.

Entities:  

Mesh:

Year:  1990        PMID: 2122130     DOI: 10.1007/bf01799522

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  14 in total

1.  [Maternal phenylketonuria].

Authors:  D P Brenton; D Fraser; M E Haseler; S Krywawych; G C Lachelin; M Lilburn; A Stewart
Journal:  Arch Fr Pediatr       Date:  1987

2.  Maternal phenylketonuria and phenylalanine restricted diet. Studies of 7 pregnancies and of offsprings produced.

Authors:  D Murphy; I Saul; M Kirby
Journal:  Ir J Med Sci       Date:  1985-02       Impact factor: 1.568

3.  Maternal phenylketonuria: successful outcome in four pregnancies treated prior to conception.

Authors:  B C Lynch; D B Pitt; T G Maddison; J E Wraith; D M Danks
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

Review 4.  Maternal phenylketonuria. Review with emphasis on pathogenesis.

Authors:  H L Levy
Journal:  Enzyme       Date:  1987

5.  Comparison of treated and untreated pregnancies in a mother with phenylketonuria.

Authors:  H L Levy; G N Kaplan; A M Erickson
Journal:  J Pediatr       Date:  1982-06       Impact factor: 4.406

6.  Maternal hyperphenylalaninemia fetal effects.

Authors:  A Lipson; B Beuhler; J Bartley; D Walsh; J Yu; M O'Halloran; W Webster
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

Review 7.  Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood.

Authors:  F Güttler
Journal:  Acta Paediatr Scand Suppl       Date:  1980

8.  Fetal damage despite low-phenylalanine diet after conception in a phenylketonuric woman.

Authors:  I Smith; M Erdohazi; F J Macartney; J R Pincott; O H Wolff; D P Brenton; S A Biddle; D V Fairweather; J Dobbing
Journal:  Lancet       Date:  1979-01-06       Impact factor: 79.321

9.  Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

Authors:  R R Lenke; H L Levy
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

10.  Progeny, pregnancy and phenylketonuria.

Authors:  R T Bush; P C Dukes
Journal:  N Z Med J       Date:  1975-10-08
View more
  6 in total

1.  Maternal phenylketonuria: the French survey.

Authors:  François Feillet; Véronique Abadie; Jacques Berthelot; Nicole Maurin; Hélène Ogier; Michel Vidailhet; Jean-Pierre Farriaux; Loic de Parscau
Journal:  Eur J Pediatr       Date:  2004-07-06       Impact factor: 3.183

2.  Psychosocial factors in maternal phenylketonuria: women's adherence to medical recommendations.

Authors:  S E Waisbren; B D Hamilton; P J St James; S Shiloh; H L Levy
Journal:  Am J Public Health       Date:  1995-12       Impact factor: 9.308

3.  Pregnancy in phenylketonuria: dietary treatment aimed at normalising maternal plasma phenylalanine concentration.

Authors:  G N Thompson; D E Francis; D M Kirby; R Compton
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

Review 4.  Gestational carrier--a reproductive haven for offspring of mothers with phenylketonuria (PKU): an alternative therapy for maternal PKU.

Authors:  R O Fisch; G Tagatz; J P Stassart
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 5.  Preconception care: delivery strategies and packages for care.

Authors:  Zohra S Lassi; Sohni V Dean; Dania Mallick; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

Review 6.  Preconception care: screening and management of chronic disease and promoting psychological health.

Authors:  Zohra S Lassi; Ayesha M Imam; Sohni V Dean; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.